Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclical vs Taxol in Recurrent Ovarian Cancer
NCT00989131Phase 3Completed
- Sponsor
- Vivesto AB
- Start
- Feb 2009
- Primary completion
- Oct 2013
- Modality
- Nanoparticles, Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of paclitaxel micellar in epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Vivesto AB. Started Feb 2009; status: completed.
02
Drugs
paclitaxel micellar
03
Conditions
epithelial ovarian cancer (EOC)primary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00989131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989131.